Chemomab Therapeutics LtdNASDAQ:CMMB
- LAST PRICE1.4400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.2600/ 5
- Ask / Lots1.9600/ 1
- Open / Previous Close--- / 1.4400
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CMMB |
|---|---|---|
| 09:32 ET | 200 | 1.36 |
| 09:35 ET | 400 | 1.37 |
| 09:37 ET | 2680 | 1.39 |
| 09:39 ET | 2370 | 1.37 |
| 09:48 ET | 1200 | 1.35 |
| 09:51 ET | 100 | 1.365 |
| 10:02 ET | 100 | 1.37 |
| 10:24 ET | 100 | 1.365 |
| 10:26 ET | 500 | 1.3526 |
| 10:38 ET | 1000 | 1.3799 |
| 10:51 ET | 100 | 1.37 |
| 11:18 ET | 930 | 1.376 |
| 11:21 ET | 100 | 1.37 |
| 11:30 ET | 100 | 1.38 |
| 11:38 ET | 1400 | 1.36 |
| 11:39 ET | 100 | 1.38 |
| 11:45 ET | 100 | 1.35 |
| 12:03 ET | 930 | 1.354 |
| 12:06 ET | 100 | 1.37 |
| 12:21 ET | 100 | 1.3501 |
| 12:55 ET | 100 | 1.365 |
| 01:11 ET | 11750 | 1.4 |
| 01:18 ET | 1971 | 1.39 |
| 01:20 ET | 1900 | 1.42 |
| 01:22 ET | 100 | 1.4 |
| 01:54 ET | 100 | 1.3925 |
| 01:56 ET | 100 | 1.39 |
| 01:58 ET | 100 | 1.3985 |
| 02:00 ET | 500 | 1.395 |
| 02:12 ET | 800 | 1.41 |
| 02:25 ET | 200 | 1.39 |
| 02:27 ET | 100 | 1.44 |
| 02:52 ET | 1750 | 1.43 |
| 02:54 ET | 1000 | 1.405 |
| 03:01 ET | 400 | 1.4 |
| 03:06 ET | 100 | 1.42 |
| 03:30 ET | 1300 | 1.4391 |
| 03:33 ET | 423 | 1.4377 |
| 03:39 ET | 1000 | 1.4027 |
| 03:42 ET | 839 | 1.4028 |
| 03:55 ET | 431 | 1.44 |
| 03:57 ET | 1000 | 1.4012 |
| 04:00 ET | 1356 | 1.44 |
Oct 30, 2024
Chemomab Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update, from 7:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
7:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
Oct 15, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Chemomab Therapeutics Ltd | 26.7M | -0.2x | --- |
GlycoMimetics Inc | 26.4M | -0.7x | --- |
Cell Source Inc | 27.3M | -4.0x | --- |
Mira Pharmaceuticals Inc | 27.3M | -2.2x | --- |
Enlivex Therapeutics Ltd | 27.8M | -1.1x | --- |
RenovoRx Inc | 24.9M | -1.7x | --- |
Company Information
Chemomab Therapeutics Ltd, formerly known as Anchiano Therapeutics Ltd, is a Israel-based biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.
Contact Information
- Headquarters
- Kiryat Atidim, Building 7TEL AVIV-YAFO, Israel 6158002
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Nissim Darvish
- Chief Executive Officer, Director
- Adi Mor
- Chief Financial Officer
- Sigal Fattal
- Chief Medical Officer, Vice President - Drug Development
- Matthew Frankel
- Independent Director
- Neil Cohen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $26.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 18.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.58 |
EPS | $-7.69 |
Book Value | $23.93 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
